Location History:
- Melzo, IT (2004)
- Monza, IT (2004)
Company Filing History:
Years Active: 2004
Title: The Innovative Contributions of Marco Pandolfi in Pharmaceutical Technology
Introduction
Marco Pandolfi, located in Monza, Italy, is an accomplished inventor with three patents to his name. His contributions primarily focus on pharmaceutical compositions of cabergoline, showcasing significant advancements in drug formulation and preparation processes.
Latest Patents
Among his notable inventions are two groundbreaking patents related to cabergoline. The first is the "Crystalline Form II of Cabergoline," which details a pharmaceutical composition that includes this crystalline form and outlines its preparation process. This process can involve the crystallization of raw cabergoline using an organic solvent at low temperatures or a slurry procedure with a mixture of cabergoline forms I and II in a solvent kept below 30°C.
The second patent is for the "Crystalline Form VII of Cabergoline." This invention also presents a pharmaceutical composition containing this form and describes its preparation. The method may include a slurry procedure that employs form I or a mixture of forms I and VII of cabergoline in a solvent at temperatures exceeding 30°C. These patents represent significant strides in enhancing the efficacy and stability of cabergoline formulations.
Career Highlights
Marco Pandolfi is currently associated with Pharmacia Italia S.p.A., where he continues to innovate in the pharmaceutical sphere. His dedication to advancing pharmaceutical technologies has made him a key figure in his field.
Collaborations
In his career, Marco has worked alongside esteemed colleagues such as Mario Ungari and Attilio Tomasi. Their collaborative efforts have undoubtedly contributed to the successful development and patenting of crucial pharmaceutical innovations.
Conclusion
Marco Pandolfi's work exemplifies the ongoing advancements in pharmaceutical innovation. His patents not only contribute to the scientific community but also enhance the potential for improved patient outcomes through innovative drug formulations. His expertise and collaboration with fellow professionals position him as a valuable asset in the realm of pharmaceutical inventions.